Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.65B |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$6.34B |
| 3 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.28B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.36B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.04B |
Top Sells
| 1 |
Texas Instruments
TXN
|
+$387M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$272M |
| 4 |
Medtronic
MDT
|
+$249M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| 1 | Technology | 21.37% |
| 2 | Financials | 10.65% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Willdan Group
WLDN
$1.48B
| $1.03M | ﹤0.01% |
35,569
+1,680
| +5% | +$48.5K |
|
2927
Vroom, Inc. Common Stock
VRM
$131M
| $1.02M | ﹤0.01% |
109,907
-32,582
| -23% | -$304K |
|
2928
Caribou Biosciences
CRBU
$166M
| $1.02M | ﹤0.01% |
621,205
-203,452
| -25% | -$334K |
|
2929
Aura Biosciences
AURA
$400M
| $1.02M | ﹤0.01% |
134,744
+28,500
| +27% | +$215K |
|
2930
Ericsson
ERIC
$26.5B
| $1.02M | ﹤0.01% |
164,745
+78,240
| +90% | +$483K |
|
2931
Century Therapeutics
IPSC
$43.9M
| $1.02M | ﹤0.01% |
398,380
+246,329
| +162% | +$628K |
|
2932
Criteo
CRTO
$1.18B
| $1.01M | ﹤0.01% |
+26,886
| New | +$1.01M |
|
2933
Vanguard Energy ETF
VDE
$7.34B
| $1.01M | ﹤0.01% |
7,922
-487
| -6% | -$62.1K |
|
2934
iRadimed
IRMD
$910M
| $1.01M | ﹤0.01% |
22,997
+3,224
| +16% | +$142K |
|
2935
Prudential
PUK
$35.5B
| $1M | ﹤0.01% |
54,652
+17,410
| +47% | +$319K |
|
|
ACRE
2936
Ares Commercial Real Estate
ACRE
$267M
| $999K | ﹤0.01% |
150,262
+11,084
| +8% | +$73.7K |
|
2937
Carter Bankshares
CARE
$450M
| $992K | ﹤0.01% |
65,633
+5,894
| +10% | +$89.1K |
|
2938
Jakks Pacific
JAKK
$195M
| $991K | ﹤0.01% |
55,345
+7,339
| +15% | +$131K |
|
2939
908 Devices
MASS
$206M
| $991K | ﹤0.01% |
192,462
-1,422
| -0.7% | -$7.32K |
|
2940
Amylyx Pharmaceuticals
AMLX
$1.05B
| $991K | ﹤0.01% |
521,619
+85,716
| +20% | +$163K |
|
2941
Latham Group
SWIM
$911M
| $987K | ﹤0.01% |
325,704
+10,711
| +3% | +$32.5K |
|
2942
NVE Corp
NVEC
$317M
| $986K | ﹤0.01% |
13,204
+449
| +4% | +$33.5K |
|
2943
Limoneira
LMNR
$269M
| $986K | ﹤0.01% |
47,386
+1,370
| +3% | +$28.5K |
|
2944
Ramaco Resources Class A
METC
$1.72B
| $986K | ﹤0.01% |
81,851
+13,410
| +20% | +$162K |
|
2945
Greenlight Captial
GLRE
$424M
| $980K | ﹤0.01% |
74,836
+6,062
| +9% | +$79.4K |
|
2946
Fox Class B
FOX
$23.1B
| $972K | ﹤0.01% |
30,365
+15,561
| +105% | +$498K |
|
2947
James Hardie Industries plc
JHX
$11.5B
| $964K | ﹤0.01% |
30,578
-703
| -2% | -$22.2K |
|
2948
Shore Bancshares
SHBI
$567M
| $964K | ﹤0.01% |
84,204
+6,560
| +8% | +$75.1K |
|
2949
Nokia
NOK
$24.6B
| $964K | ﹤0.01% |
254,899
+84,909
| +50% | +$321K |
|
2950
Taysha Gene Therapies
TSHA
$887M
| $963K | ﹤0.01% |
429,744
+378,282
| +735% | +$847K |
|